1. Home
  2. Analysis
  3. Adenoscan
  4. Vertigo-aggravated

Adenoscan and Vertigo aggravated - a phase IV clinical study of FDA data

Summary:

Vertigo aggravated is reported as a side effect among people who take Adenoscan (adenosine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cardiolite,.

The phase IV clinical study analyzes which people have Vertigo aggravated when taking Adenoscan. It is created by eHealthMe based on reports of 480 people who have side effects when taking Adenoscan from the FDA, and is updated regularly.

What is Adenoscan?

Adenoscan has active ingredients of adenosine. eHealthMe is studying from 482 Adenoscan users. Check the latest studies of Adenoscan.

What is Vertigo aggravated?

Vertigo aggravated is found to be associated with 2,551 drugs and 716 conditions by eHealthMe. Check the latest studies of Vertigo aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

480 people reported to have side effects when taking Adenoscan.
Among them, 16 people (3.33%) have Vertigo aggravated.

Could Adenoscan cause Vertigo aggravated?

Among these 16 people:

How long have people been on Adenoscan when they have Vertigo aggravated? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Vertigo aggravated when taking Adenoscan? *

  • female: 64.29 %
  • male: 35.71 %

What is the age of people who have Vertigo aggravated when taking Adenoscan? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 14.29 %
  • 50-59: 0.0 %
  • 60+: 85.71 %

What are other drugs people take besides Adenoscan? *

  1. Cardiolite: 3 people, 18.75%
  2. Lexapro: 2 people, 12.50%
  3. Toprol-Xl: 2 people, 12.50%
  4. Hydrochlorothiazide: 2 people, 12.50%
  5. Welchol: 1 person, 6.25%
  6. Atenolol: 1 person, 6.25%
  7. Benadryl: 1 person, 6.25%
  8. Clonidine: 1 person, 6.25%
  9. Coumadin: 1 person, 6.25%
  10. Diovan: 1 person, 6.25%

What are other side effects people have besides Vertigo aggravated? *

  1. Nausea (feeling of having an urge to vomit): 9 people, 56.25%
  2. Chest Pain: 8 people, 50.00%
  3. Headache (pain in head): 7 people, 43.75%
  4. Hypotension (abnormally low blood pressure): 7 people, 43.75%
  5. Dyspnea (difficult or laboured breathing): 6 people, 37.50%
  6. Diarrhea: 5 people, 31.25%
  7. Nausea And Vomiting: 4 people, 25.00%
  8. Malaise (a feeling of general discomfort or uneasiness): 3 people, 18.75%
  9. Feeling Hot: 2 people, 12.50%
  10. Heart Rate Increased: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Adenoscan and have Vertigo aggravated?

- Check whether Vertigo aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adenoscan:

Vertigo aggravated treatments and more:

How severe was Vertigo aggravated and when was it recovered:

Expand to all the drugs that have ingredients of adenosine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adenoscan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vertigo aggravated:

Browse all the conditions that are associated with Vertigo aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on adenosine (the active ingredients of Adenoscan) and Adenoscan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.